UltraShape CONTOUR I to be Included in Four Presentations at the Aesthetic Meeting 2007

Hot Topics

Ascher was selected to present on his extensive experience using the UltraShape CONTOUR I in his plastic surgery practice in Paris, France. His data following three treatments at three week intervals demonstrated that 92% of his patients experienced measurable circumference reduction. In addition, 88% of patients expressed satisfaction with their results. Ascher noted the importance of appropriate patient selection and setting the right expectations.

“Through my own studies I have seen that most of the patients not only respond well to the treatment, but also express great satisfaction due to the convenience of the ‘walk-in, walk-out’ session and no requirements for maintenance treatments,” explained Ascher. ”I have found that the UltraShape CONTOUR I system is an effective non-invasive body contouring solution for the abdomen, flanks and thighs and could possibly be considered an alternative to conventional liposuction for the appropriate candidates.”

Dr. Ascher is a leading plastic surgeon specializing in plastic, aesthetic and reconstructive surgery and body contouring. He is a member of the French Society of Plastic, Aesthetic and Reconstructive Surgery (SOFPRE). He is the Scientific Director of IMCAS Congresses, International Master Courses on Aging Skin and teacher leader in Europe for Plastic Surgeons and Cosmetic Dermatologists.

Additional Presentations at ASAPS Highlighting UltraShape

In addition to the Hot Topics panel, UltraShape will be featured in the following presentations:

• Friday, April 20, 2007 – Advances in Minimally Invasive Face & Body Rejuvenation Featuring Live Patient Demonstrations: “Non-Surgical Fat Removal” By: Jeffrey M. Kenkel, M.D., Professor and Vice Chairman of the Department of Plastic Surgery at the University of Texas Southwestern Medical Center at Dallas and Chairman, UltraShape North America Medical Advisory Board.
• Sunday, April 22, 2007 – Ancillary Light, Radiofrequency, Ultrasound, and Wire-Release Procedures in Your Practice: “Introduction and Review of Clinical Studies to Date of Non-Invasive Body Contouring using UltraShape” By: Gordon Sasaki, M.D., Clinical Professor of Plastic Surgery at Loma Linda University Medical School.
• Tuesday, April 24, 2007 – Minimally Invasive Body Contouring Surgery: “Non-Invasive Body Contouring With Focused Ultrasound Using UltraShape CONTOUR I” By: Steven Teitelbaum, M.D., Assistant Clinical Professor of Plastic Surgery at the David Geffen School of Medicine at UCLA, Medical Director of the Santa Monica Institute of Laser and Esthetic Surgery, Member, UltraShape North America Medical Advisory Board, and Principal Clinical Investigator in UltraShape’s completed and published multi-center worldwide controlled clinical study.

“These presentations further conclude that the UltraShape CONTOUR I has been scientifically demonstrated to produce definitive, measurable circumference and fat thickness reduction without pain or downtime. It has also been shown to selectively target and disrupt fat without harming surrounding tissues,“ said Kenkel.

About the UltraShape CONTOUR I

The UltraShape CONTOUR I system, based on patented focused ultrasound technology, is the first clinically proven non-invasive body contouring solution for both men and women. It is designed to target and disrupt fat, leaving surrounding structures such as skin, blood vessels, and nerves intact. The UltraShape procedure is guided by proprietary real-time tracking and guidance software designed to deliver smooth, uniform body contouring results. The software guarantees adherence to a pre-determined treatment algorithm minimizing risk of contour irregularities, a common side effect of liposuction which is a highly technique-sensitive surgical procedure.

The UltraShape procedure is performed during a convenient, “walk-in, walk-out” session carried out in an office-based environment; it requires no anesthesia or sedation, and the vast majority of patients report no pain or discomfort. After treatment, patients immediately resume their daily routines and there is no need for maintenance treatments. The UltraShape CONTOUR I system received the CE Mark in July 2005 and is currently distributed in 45 countries outside of the United States. Over 30,000 commercial treatments have been performed worldwide with high patient satisfaction.

About UltraShape

Contact